The Australian Technical Advisory Group on Immunisation (ATAGI) now recommends deferring vaccination with any COVID-19 vaccine for people who have a history of cerebral venous sinus thrombosis (CVST) or heparin induced thrombocytopenia (HIT). “A HIT-like mechanism is being investigated as a potential, but unconfirmed, pathway to CVST post COVID-19 vaccination,” it said in a statement ...
Avoid COVID-19 vaccination for patients with HIT-like clotting disorder: ATAGI
By Dave Levitan
31 Mar 2021